University of Rhode Island Clinical Professor of Pharmacy Jeffrey Bratberg partnered with Brandeis University and Boston ...

JailsoutpaceprisonsinofferingMOUD,butregionaldisparitiesandlimitedtreatmentaccess persist across the U.S. Qualitativefeedbackpointstoneedforgreaterreentrysupport,housing,carecoord ...

Patients who are prescribed higher daily doses of the medication buprenorphine for opioid use disorder are significantly more ...

Opioid use disorder (OUD) is a serious and complex condition affecting millions of people across the country and contributing to a national public health emergency. Yet stigma and misinformation about ...

Early evidence suggests GLP-1s were linked to lower risks of developing substance use disorders — from alcohol to opioids — ...

Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, ...

Individuals with opioid use disorder can get “stuck” in particular patterns of brain activity, a new Yale study finds. And this stickiness is more pronounced after they’ve seen images related to ...

GLP-1 receptor agonists were associated with reduced risk of alcohol, cannabis, cocaine, nicotine and opioid use disorders, ...

The national Six Remnant Defendants lawsuit was brought Feb. 23. The total compensation paid to participating governments ...

Dr. Sarah Spencer sits in the back of the Ninilchik Community Clinic's mobile clinic, assembling an opioid harm-reduction kit. Medications like buprenorphine are important tools in the spectrum of ...

A new review shows insufficient or low-quality evidence to suggest cannabinoids are effective at treating most psychiatric conditions and substance use disorders.

Cannabis compounds may reduce symptoms for some disorders, but evidence quality is low ...